NCT00049361 Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Status COMPLETED Phase PHASE2
NCT00047294 Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00039494 Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors Status COMPLETED Phase PHASE2
NCT00034697 Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) Status TERMINATED Phase PHASE2
NCT00033709 Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma Status UNKNOWN Phase PHASE2
NCT00033280 Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas Status COMPLETED Phase PHASE2
NCT00028795 Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma Status COMPLETED Phase PHASE2
NCT00027742 Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00027625 Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma Status COMPLETED Phase PHASE1
NCT00026494 Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases Status COMPLETED Phase PHASE1/PHASE2
NCT00025558 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer Status COMPLETED Phase PHASE1
NCT00022711 Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00021307 Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme Status WITHDRAWN Phase PHASE1/PHASE2
NCT00020839 Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain Status TERMINATED Phase PHASE3
NCT00020150 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors Status COMPLETED Phase PHASE1
NCT00016055 Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma Status UNKNOWN Phase PHASE1
NCT00014261 Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00014105 Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme Status UNKNOWN Phase PHASE1/PHASE2
NCT00014092 Chemotherapy Followed by Biological Therapy in Treating Patients With Stage IV Melanoma That Cannot be Treated With Surgery Status COMPLETED Phase PHASE2
NCT00012116 Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain Status COMPLETED Phase PHASE2